VOL. 40, NO. 6
FEBRUARY 11 - 17, 2019
Source Lunch
Akron
Yael Ron, Ritz-Carlton Cleveland general manager
Akron-Canton Airport hoping smooth skies are ahead. Page 24
Page 27
The List
CLEVELAND BUSINESS
Largest commercial property sales Page 15
REAL ESTATE
Cleveland apartment vacancy stands out By Stan Bullard
Centric occupies a University Circle site on Mayfield Road near Little Italy. The building’s exterior colors are designed to reflect the palette of the nearby ethnic neighborhood. (Stan Bullard)
sbullard@crain.com @CrainRltyWriter
Amid a building spurt, apartment vacancy in the Cleveland region ticked up to 6% at the end of 2018, from 5.8% a year earlier. The data from the Marcus & Millichap investment real estate brokerage also put the Metropolitan Statistical Area in a spot it rarely sees in good economic times, as the fourth-highest in the firm’s rankings of markets nationally. That company includes San Antonio, which leads the nation with a 6.8% vacancy rate, followed by Houston with 6.4% and St. Louis at 6.1%. Even though vacancies are up thanks to lots of new suites hitting the market — by Cleveland standards — there’s no perceptible whining from insiders. In an oft-repeated phrase among multifamily owners and developers, Ari Maron, spokesman for the Cleveland-based MRN realty company, which produced the East Fourth Neighborhood and Uptown retail/ multifamily properties, said he’s bullish about the region’s apartment market. “The market seems very strong,” Maron said in a phone interview as he discussed the company’s project to open: the 25-suite Market District Lofts in part of an Ohio City office building. At Uptown, 11471 Euclid Ave., MRN’s complex with first-floor retail and upper-level apartments at University Circle, occupancy is almost 100%. And that’s after the nearby One University Circle and Centric projects opened the doors to a total of 548 suites last year. Each is barely less than half a year into its rent-up period. SEE VACANCIES, PAGE 25
Cleveland, U.S. apartment vacancy rates 6%
Cleveland
U.S. average
Cleveland
6.0%
U.S. average
$1,500
5.1%
$900
3%
$1,400
6.0%
$1,242
$1,200
$940
$874
$600 $300
0
2016
2017
2018
2019
SOURCE: Marcus & Millichap 2019 Multifamily North American forecast
FOCUS: MIDDLE MARKET
MobilityWorks plans expansion Richfield-based dealer of accessible vehicles aims for 40 new locations in four years. Page 10 Entire contents © 2019 by Crain Communications Inc.
0
2016
2017
2018
2019
SOURCE: Marcus & Millichap 2019 Multifamily North American forecast
Crain’s graphic
HEALTH CARE
Regenerative medicine growing strong in region and elsewhere
By Lydia Coutré lcoutre@crain.com @LydiaCoutre
Biotech company CavoGene LifeSciences has licensed a novel investigational gene therapy from the University of California San Diego and brought the technology across the country to Cleveland, where the six-month-old firm will be headquartered. The move — facilitated by Cleveland’s health care and bioscience business accelerator, BioEnterprise
P001_CL_20190211.indd 1
Effective monthly rates
— comes as the regenerative medicine industry is seeing a surge in investment, promising clinical trials and strong partnering opportunities. In 2018, financing for regenerative medicine — which includes cell therapies, gene therapies and tissue-engineering products — reached $13.3 billion, topping the amount raised in 2015, an industry spike that had been seen as the year to beat, according to officials with the Alliance for Regenerative Medicine (ARM), a D.C.-based alliance of stakeholders interested in advancing the therapies around the world.
In 2015, the industry attracted a dramatic $9.4 billion in investment. After a couple of years that fell off from that peak, 2018’s numbers surpassed it. “A lot of investment is being made in the sector,” said Janet Lynch Lambert, CEO of ARM. “And that in turn is driving company growth and more clinical trials and more work in this space. So the overall story for the sector in 2018 was a very good-news story. A lot of advancement in the science and in the commercialization of these technologies in the U.S. and abroad.” SEE MEDICINE, PAGE 24
2/8/19 3:25 PM